Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Structure-Function Implications of the Ability of Monoclonal Antibodies Against α-Galactosylceramide-CD1d Complex to Recognize β-Mannosylceramide Presentation by CD1d.
Clark K, Yau J, Bloom A, Wang J, Venzon DJ, Suzuki M, Pasquet L, Compton BJ, Cardell SL, Porcelli SA, Painter GF, Zajonc DM, Berzofsky JA, Terabe M. Clark K, et al. Among authors: terabe m. Front Immunol. 2019 Oct 9;10:2355. doi: 10.3389/fimmu.2019.02355. eCollection 2019. Front Immunol. 2019. PMID: 31649670 Free PMC article.
Targeting the CD47/thrombospondin-1 signaling axis regulates immune cell bioenergetics in the tumor microenvironment to potentiate antitumor immune response.
Stirling ER, Terabe M, Wilson AS, Kooshki M, Yamaleyeva LM, Alexander-Miller MA, Zhang W, Miller LD, Triozzi PL, Soto-Pantoja DR. Stirling ER, et al. Among authors: terabe m. J Immunother Cancer. 2022 Nov;10(11):e004712. doi: 10.1136/jitc-2022-004712. J Immunother Cancer. 2022. PMID: 36418073 Free PMC article.
A push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L.
Ahlers JD, Belyakov IM, Terabe M, Koka R, Donaldson DD, Thomas EK, Berzofsky JA. Ahlers JD, et al. Among authors: terabe m. Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13020-5. doi: 10.1073/pnas.192251199. Epub 2002 Sep 13. Proc Natl Acad Sci U S A. 2002. PMID: 12232042 Free PMC article.
Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.
Terabe M, Matsui S, Park JM, Mamura M, Noben-Trauth N, Donaldson DD, Chen W, Wahl SM, Ledbetter S, Pratt B, Letterio JJ, Paul WE, Berzofsky JA. Terabe M, et al. J Exp Med. 2003 Dec 1;198(11):1741-52. doi: 10.1084/jem.20022227. J Exp Med. 2003. PMID: 14657224 Free PMC article.
Immunoregulatory T cells in tumor immunity.
Terabe M, Berzofsky JA. Terabe M, et al. Curr Opin Immunol. 2004 Apr;16(2):157-62. doi: 10.1016/j.coi.2004.01.010. Curr Opin Immunol. 2004. PMID: 15023407 Review.
124 results